Sunday, 20 September 2026European Markets

PROACTIS Stock Jumps 21% As Market Outperforms At End Of Wednesday Session

Loading stream...

(vianews) -

about proactis sa

proactis sa is an industry leader when it comes to source-to-pay software solutions that enable businesses to gain better control over their spending. with an expansive platform, this company provides procurement solutions designed to simplify purchasing of routine goods and services, capital goods, and major projects. proactis sa provides services such as invoice capture services, system administration, supplier onboarding, tail spend management services and seamless integration with various erp or financial systems. based in suresnes, france - as a subsidiary of proactis euro hedgeco limited - proactis sa stands out by delivering top quality software solutions designed to optimize procurement processes within businesses.

yearly analysis

according to available data, proactis sa's stock is trading at eur0.05 at present - below its 52-week high of eur0.12 but above its low of eur0.04. this suggests a period of volatility within its past year. investors may wish to take this information into account when assessing a stock's current standing and potential for future growth. furthermore, investors may wish to analyze other metrics, such as financial performance and industry trends in order to gain a fuller picture of the value and returns associated with each stock they own.

technical analysis

proactis sa has been trading below both its 50-day and 200-day moving averages, which indicates a downward trend in price. even though trading volume increased by 59.66% recently, proactis' stock failed to capitalize on this momentum and remains under significant strain. proactis sa's stock has shown increasing levels of volatility over the last week, month and quarter; its intraday variation average ranging from an 8.21% decrease to 10.03% increase respectively over these timespan. last week saw its highest average volatility amplitude at 10.66%; an indicator of high uncertainty regarding price movements of its shares. according to the stochastic oscillator, proactis sa's stock may be overbought (>=80), signalling that a potential correction could come soon. overall, proactis sa stock is currently trading below its moving averages and experiencing high volatility, suggesting overbuying. investors should use caution and closely track its price movements before making any investment decisions.

quarter analysis

over the past twelve months, revenue growth at our company has seen a decline of 3.6% to total 14.11m. this slower-than-average growth could signal challenges with expanding business operations.

equity analysis

as per the provided data, proactis sa has posted negative earnings during its most recent twelve month period, with an eps of eur-0.01 representing negative earnings relative to shareholder's equity. furthermore, its return on equity stood at -3.88% indicating it has not generated substantial returns for shareholders over this timeframe. investors should carefully consider this information prior to making investment decisions.

more news about proactis sa (proac.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com